ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024
Peripheral risk factors and their role in biomarker-based screening for dementia in the community.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Anemia, iron deficiency, and blood biomarkers for Alzheimer disease: clinical interpretation and dementia risk stratification.Frontiers in nutrition · 2026Review
- A machine learning framework for classifying dementia risk in mild cognitive impairment: evidence from a Korean genome-wide association study cohort.Alzheimer's research & therapy · 2025Article
- Investigating the contribution of laboratory parameters on plasma neurofilament light chain levels in multiple sclerosis.Frontiers in neurology · 2025Article
- Peripheral risk factors and their role in biomarker-based screening for dementia in the community.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionPeripheral risk factors (PRFs) may correlate with dementia plasma biomarkers, potentially reflecting peripheral rather than brain health. This study explores the associations between PRFs and plasma biomarkers glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and total-tau, and their role in predicting future dementia.
methodsData from the Age, Gene/Environment Susceptibility-Reykjavik Study (2002-2015) included 4353 participants mean age of 76.6 years. A subsample of 910 participants tested their association with PRFs and plasma biomarkers' predictive performance. Sociodemographic, clinical, laboratory, sensory, and lifestyle variables (n = 305) were grouped into 34 clusters.
resultsBesides age and estimated glomerular filtration rate (eGFR), significant associations were found between plasma biomarkers and clusters related to hemoglobin, red blood cell distribution, and inflammation. Incorporating these clusters into predictive models enhanced precision and sensitivity, though overall prediction improvement was modest (area under the precision-recall curve: GFAP 0.17 to 0.34, NfL 0.20 to 0.38). DISCUSSION: PRFs are significantly associated with dementia plasma biomarkers; Considering these factors may enhance the predictive accuracy of dementia biomarkers. HIGHLIGHTS: Machine learning identifies key peripheral factors influencing neurodegenerative biomarkers. Hemoglobin and red blood cell distribution cluster associates significantly with biomarker levels. Incorporating diverse peripheral factors modestly enhances incident dementia prediction accuracy in community settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.